Skip to main content
Top
Published in: Supportive Care in Cancer 4/2024

01-04-2024 | Fatigue | Research

Early change in fatigue, insomnia, and cognitive impairment and symptom severity 3 years post-treatment in breast cancer survivors

Authors: Rachel M. Lee, Joshua A. Rash, Melanie Seal, Joy McCarthy, Sheila N. Garland

Published in: Supportive Care in Cancer | Issue 4/2024

Login to get access

Abstract

Purpose

Breast cancer is the most common form of cancer among Canadian women. Survivorship challenges include fatigue, sleep disturbance, and cognitive impairment. This study examined (1) symptom trajectory from diagnosis to 3 years; (2) whether symptom change in the first 4 months was associated with prolonged difficulties after 3 years; and (3) which factors were associated with deterioration in symptoms during the first 4 months.

Methods

This prospective observational cohort study examined 53 women (Mage = 58.6, 96.2% White, 67.9% stage I) with newly diagnosed breast cancer over 3 years. Women completed assessments before starting treatment, 4 months, and 3 years after diagnosis. Three-way repeated-measures ANOVAs evaluated symptom trajectories. A repeated-measures mediation analysis was performed to determine if change from pre-treatment to 4 months accounted for change from pre-treatment to 3 years. A series of between-subjects ANOVAs were used to determine what variables significantly differed by deterioration status.

Results

Perceived cognitive impairment and fatigue increased linearly from diagnosis to 3 years. Change in fatigue in the first 4 months fully accounted for its change over 3 years. Insomnia severity and sleep quality deteriorated from diagnosis to 4 months, but returned to pre-treatment levels at 3 years. Those whose fatigue and cognitive ability deteriorated during the first 4 months were younger.

Conclusion

Efforts to identify those who are at risk of experiencing fatigue, sleep disturbance, and cognitive impairment; monitor patients early after receiving a diagnosis; and provide targeted interventions may prevent long-term deterioration and improve well-being.
Literature
2.
go back to reference Committee CCSA (2022) Canadian Cancer Statistics 2022. [cited 2022 December 14, 2022]. Committee CCSA (2022) Canadian Cancer Statistics 2022. [cited 2022 December 14, 2022].
4.
go back to reference Cella D et al (2002) Fatigue in cancer patients compared with fatigue in the general United States population. Cancer 94(2):528–538PubMedCrossRef Cella D et al (2002) Fatigue in cancer patients compared with fatigue in the general United States population. Cancer 94(2):528–538PubMedCrossRef
6.
go back to reference Jacobsen PB et al (1999) Fatigue in women receiving adjuvant chemotherapy for breast cancer: characteristics, course, and correlates. J Pain Symptom Manage 18(4):233–242PubMedCrossRef Jacobsen PB et al (1999) Fatigue in women receiving adjuvant chemotherapy for breast cancer: characteristics, course, and correlates. J Pain Symptom Manage 18(4):233–242PubMedCrossRef
7.
go back to reference Stein KD et al (1998) A multidimensional measure of fatigue for use with cancer patients. Cancer Pract 6(3):143–152PubMedCrossRef Stein KD et al (1998) A multidimensional measure of fatigue for use with cancer patients. Cancer Pract 6(3):143–152PubMedCrossRef
9.
go back to reference Alexander S et al (2009) A comparison of the characteristics of disease-free breast cancer survivors with or without cancer-related fatigue syndrome. Eur J Cancer 45(3):384–392PubMedPubMedCentralCrossRef Alexander S et al (2009) A comparison of the characteristics of disease-free breast cancer survivors with or without cancer-related fatigue syndrome. Eur J Cancer 45(3):384–392PubMedPubMedCentralCrossRef
10.
go back to reference Ruiz-Casado A et al (2021) Cancer-related fatigue in breast cancer survivors: a review. Clin Breast Cancer 21(1):10–25PubMedCrossRef Ruiz-Casado A et al (2021) Cancer-related fatigue in breast cancer survivors: a review. Clin Breast Cancer 21(1):10–25PubMedCrossRef
11.
go back to reference Bean HR et al (2021) Insomnia and fatigue symptom trajectories in breast cancer: a longitudinal cohort study. Behav Sleep Med 19(6):814–827PubMedCrossRef Bean HR et al (2021) Insomnia and fatigue symptom trajectories in breast cancer: a longitudinal cohort study. Behav Sleep Med 19(6):814–827PubMedCrossRef
12.
go back to reference Janz NK et al (2007) Symptom experience and quality of life of women following breast cancer treatment. J Womens Health (Larchmt) 16(9):1348–1361PubMedCrossRef Janz NK et al (2007) Symptom experience and quality of life of women following breast cancer treatment. J Womens Health (Larchmt) 16(9):1348–1361PubMedCrossRef
13.
14.
go back to reference APA (2013) The diagnostic and statistical manual of mental disorders, Fifth Edition. American Psychiatric Association, Washington, DC APA (2013) The diagnostic and statistical manual of mental disorders, Fifth Edition. American Psychiatric Association, Washington, DC
15.
go back to reference Savard J, Morin CM (2001) Insomnia in the context of cancer: a review of a neglected problem. J Clin Oncol 19(3):895–908PubMedCrossRef Savard J, Morin CM (2001) Insomnia in the context of cancer: a review of a neglected problem. J Clin Oncol 19(3):895–908PubMedCrossRef
16.
go back to reference Henneghan AM et al (2018) Relationships between self-reported sleep quality components and cognitive functioning in breast cancer survivors up to 10 years following chemotherapy. Psychooncology 27(8):1937–1943PubMedCrossRef Henneghan AM et al (2018) Relationships between self-reported sleep quality components and cognitive functioning in breast cancer survivors up to 10 years following chemotherapy. Psychooncology 27(8):1937–1943PubMedCrossRef
17.
go back to reference Lowery-Allison AE et al (2018) Sleep problems in breast cancer survivors 1–10 years posttreatment. Palliat Support Care 16(3):325–334PubMedCrossRef Lowery-Allison AE et al (2018) Sleep problems in breast cancer survivors 1–10 years posttreatment. Palliat Support Care 16(3):325–334PubMedCrossRef
18.
go back to reference Bower JE (2008) Behavioral symptoms in patients with breast cancer and survivors. J Clin Oncol 26(5):768–777PubMedCrossRef Bower JE (2008) Behavioral symptoms in patients with breast cancer and survivors. J Clin Oncol 26(5):768–777PubMedCrossRef
20.
go back to reference Savard J, Ganz PA (2016) Subjective or objective measures of cognitive functioning-what’s more important? JAMA Oncol 2(10):1263–1264PubMedCrossRef Savard J, Ganz PA (2016) Subjective or objective measures of cognitive functioning-what’s more important? JAMA Oncol 2(10):1263–1264PubMedCrossRef
21.
go back to reference Castellon SA et al (2004) Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen. J Clin Exp Neuropsychol 26(7):955–969PubMedCrossRef Castellon SA et al (2004) Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen. J Clin Exp Neuropsychol 26(7):955–969PubMedCrossRef
22.
go back to reference Caplette-Gingras A et al (2013) Is insomnia associated with cognitive impairments in breast cancer patients? Behav Sleep Med 11(4):239–257PubMedCrossRef Caplette-Gingras A et al (2013) Is insomnia associated with cognitive impairments in breast cancer patients? Behav Sleep Med 11(4):239–257PubMedCrossRef
23.
go back to reference Ahles TA et al (2002) Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. J Clin Oncol 20(2):485–493PubMedCrossRef Ahles TA et al (2002) Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. J Clin Oncol 20(2):485–493PubMedCrossRef
24.
go back to reference Stone P et al (2000) Cancer-related fatigue: inevitable, unimportant and untreatable? Results of a multi-centre patient survey. Cancer Fatigue Forum Ann Oncol 11(8):971–975PubMed Stone P et al (2000) Cancer-related fatigue: inevitable, unimportant and untreatable? Results of a multi-centre patient survey. Cancer Fatigue Forum Ann Oncol 11(8):971–975PubMed
25.
go back to reference Henneghan A et al (2018) Modifiable correlates of perceived cognitive function in breast cancer survivors up to 10 years after chemotherapy completion. J Cancer Surviv 12(2):224–233PubMedCrossRef Henneghan A et al (2018) Modifiable correlates of perceived cognitive function in breast cancer survivors up to 10 years after chemotherapy completion. J Cancer Surviv 12(2):224–233PubMedCrossRef
26.
go back to reference Chan A et al (2018) Minimal clinically important difference of the Multidimensional Fatigue Symptom Inventory-Short Form (MFSI-SF) for fatigue worsening in Asian breast cancer patients. J Pain Symptom Manage 55(3):992-997 e2PubMedCrossRef Chan A et al (2018) Minimal clinically important difference of the Multidimensional Fatigue Symptom Inventory-Short Form (MFSI-SF) for fatigue worsening in Asian breast cancer patients. J Pain Symptom Manage 55(3):992-997 e2PubMedCrossRef
27.
go back to reference Morin CM (1993) Insomnia: psychological assessment and management. Guilford, New York Morin CM (1993) Insomnia: psychological assessment and management. Guilford, New York
28.
go back to reference Morin CM et al (2011) The Insomnia Severity Index: psychometric indicators to detect insomnia cases and evaluate treatment response. Sleep 34(5):601–608PubMedPubMedCentralCrossRef Morin CM et al (2011) The Insomnia Severity Index: psychometric indicators to detect insomnia cases and evaluate treatment response. Sleep 34(5):601–608PubMedPubMedCentralCrossRef
29.
go back to reference Yang M et al (2009) Interpreting score differences in the Insomnia Severity Index: using health-related outcomes to define the minimally important difference. Curr Med Res Opin 25(10):2487–2494PubMedCrossRef Yang M et al (2009) Interpreting score differences in the Insomnia Severity Index: using health-related outcomes to define the minimally important difference. Curr Med Res Opin 25(10):2487–2494PubMedCrossRef
30.
go back to reference Buysse DJ et al (1989) The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 28(2):193–213PubMedCrossRef Buysse DJ et al (1989) The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 28(2):193–213PubMedCrossRef
31.
go back to reference Longo UG et al (2021) Minimal clinically important difference and patient acceptable symptom state for the Pittsburgh Sleep Quality Index in patients who underwent rotator cuff tear repair. Int J Environ Res Public Health 18(16):8666 Longo UG et al (2021) Minimal clinically important difference and patient acceptable symptom state for the Pittsburgh Sleep Quality Index in patients who underwent rotator cuff tear repair. Int J Environ Res Public Health 18(16):8666
32.
go back to reference Wagner LI et al (2009) Measuring patient self-reported cognitive function: development of the functional assessment of cancer therapy-cognitive function instrument. J Support Oncol 7(6):W32–W39 Wagner LI et al (2009) Measuring patient self-reported cognitive function: development of the functional assessment of cancer therapy-cognitive function instrument. J Support Oncol 7(6):W32–W39
33.
go back to reference Cheung YT et al (2014) Minimal clinically important difference (MCID) for the functional assessment of cancer therapy: cognitive function (FACT-Cog) in breast cancer patients. J Clin Epidemiol 67(7):811–820PubMedCrossRef Cheung YT et al (2014) Minimal clinically important difference (MCID) for the functional assessment of cancer therapy: cognitive function (FACT-Cog) in breast cancer patients. J Clin Epidemiol 67(7):811–820PubMedCrossRef
34.
go back to reference Bell ML et al (2018) Important differences and meaningful changes for the Functional Assessment of Cancer Therapy-Cognitive Function (FACT-Cog). J Patient-Reported Outcomes 2:48 Bell ML et al (2018) Important differences and meaningful changes for the Functional Assessment of Cancer Therapy-Cognitive Function (FACT-Cog). J Patient-Reported Outcomes 2:48
35.
go back to reference Montoya AK, Hayes AF (2017) Two-condition within-participant statistical mediation analysis: a path-analytic framework. Psychol Methods 22(1):6–27PubMedCrossRef Montoya AK, Hayes AF (2017) Two-condition within-participant statistical mediation analysis: a path-analytic framework. Psychol Methods 22(1):6–27PubMedCrossRef
36.
go back to reference Williams AM et al (2021) Fatigue, anxiety, and quality of life in breast cancer patients compared to non-cancer controls: a nationwide longitudinal analysis. Breast Cancer Res Treat 187(1):275–285PubMedPubMedCentralCrossRef Williams AM et al (2021) Fatigue, anxiety, and quality of life in breast cancer patients compared to non-cancer controls: a nationwide longitudinal analysis. Breast Cancer Res Treat 187(1):275–285PubMedPubMedCentralCrossRef
37.
go back to reference Geinitz H et al (2001) Fatigue, serum cytokine levels, and blood cell counts during radiotherapy of patients with breast cancer. Int J Radiat Oncol Biol Phys 51(3):691–698PubMedCrossRef Geinitz H et al (2001) Fatigue, serum cytokine levels, and blood cell counts during radiotherapy of patients with breast cancer. Int J Radiat Oncol Biol Phys 51(3):691–698PubMedCrossRef
38.
go back to reference Sanford SD et al (2013) Longitudinal prospective assessment of sleep quality: before, during, and after adjuvant chemotherapy for breast cancer. Support Care Cancer 21(4):959–967PubMedCrossRef Sanford SD et al (2013) Longitudinal prospective assessment of sleep quality: before, during, and after adjuvant chemotherapy for breast cancer. Support Care Cancer 21(4):959–967PubMedCrossRef
39.
go back to reference Weng YP et al (2021) Sleep quality and related factors in patients with breast cancer: a cross-sectional study in Taiwan. Cancer Manag Res 13:4725–4733PubMedPubMedCentralCrossRef Weng YP et al (2021) Sleep quality and related factors in patients with breast cancer: a cross-sectional study in Taiwan. Cancer Manag Res 13:4725–4733PubMedPubMedCentralCrossRef
40.
go back to reference Zeng Y et al (2017) Subjective cognitive impairment and brain structural networks in Chinese gynaecological cancer survivors compared with age-matched controls: a cross-sectional study. BMC Cancer 17(1):796PubMedPubMedCentralCrossRef Zeng Y et al (2017) Subjective cognitive impairment and brain structural networks in Chinese gynaecological cancer survivors compared with age-matched controls: a cross-sectional study. BMC Cancer 17(1):796PubMedPubMedCentralCrossRef
41.
go back to reference Adak S et al (2020) Cognitive score in patients with primary brain tumors undergoing systemic therapy – a cross-sectional study. Cancer Res Stats Treat 3(3):455–460CrossRef Adak S et al (2020) Cognitive score in patients with primary brain tumors undergoing systemic therapy – a cross-sectional study. Cancer Res Stats Treat 3(3):455–460CrossRef
42.
go back to reference Vardy JL et al (2019) A mechanistic cohort study evaluating cognitive impairment in women treated for breast cancer. Brain Imaging Behav 13(1):15–26PubMedCrossRef Vardy JL et al (2019) A mechanistic cohort study evaluating cognitive impairment in women treated for breast cancer. Brain Imaging Behav 13(1):15–26PubMedCrossRef
43.
go back to reference Brownstein CG et al (2022) Physiological and psychosocial correlates of cancer-related fatigue. J Cancer Surviv 16(6):1339–1354PubMedCrossRef Brownstein CG et al (2022) Physiological and psychosocial correlates of cancer-related fatigue. J Cancer Surviv 16(6):1339–1354PubMedCrossRef
44.
go back to reference Schulte FSM et al (2021) Quality of life among survivors of adolescent and young adult cancer in Canada: a young adults with cancer in their prime (YACPRIME) study. Cancer 127(8):1325–1333PubMedCrossRef Schulte FSM et al (2021) Quality of life among survivors of adolescent and young adult cancer in Canada: a young adults with cancer in their prime (YACPRIME) study. Cancer 127(8):1325–1333PubMedCrossRef
45.
go back to reference Vanrusselt D et al (2023) Associations between cancer-related distress and fatigue in childhood cancer survivors: a longitudinal study. Psychooncology 32(3):393–400PubMedCrossRef Vanrusselt D et al (2023) Associations between cancer-related distress and fatigue in childhood cancer survivors: a longitudinal study. Psychooncology 32(3):393–400PubMedCrossRef
Metadata
Title
Early change in fatigue, insomnia, and cognitive impairment and symptom severity 3 years post-treatment in breast cancer survivors
Authors
Rachel M. Lee
Joshua A. Rash
Melanie Seal
Joy McCarthy
Sheila N. Garland
Publication date
01-04-2024
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 4/2024
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-024-08418-1

Other articles of this Issue 4/2024

Supportive Care in Cancer 4/2024 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine